Webinar | September 9, 2024

Intensifying Downstream Bioprocessing With Continuous Technologies

Source: Cytiva

The shift from traditional batch processes to intensified continuous processes is more than just a trend—it's the future of monoclonal antibody (mAb) production. Cytiva recognizes the need for more cost-effective and efficient solutions in this field.

This webinar explores intensified downstream bioprocessing in depth, covers common bottlenecks, and introduces continuous processing solutions capable of transforming your mAb platform. Discover how to streamline your polishing step with single flow-through chromatography or boost efficiency using single-pass Tangential Flow Filtration (TFF). Further, gain insight into strategies to intensify capture chromatography and viral inactivation for unparalleled outcomes.

Watch to take a step toward a more innovative and efficient future in bioprocessing.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma